الشكل التوضيحي التكميلي S2 من RLY-4008، أول مثبط انتقائي عالي لـ FGFR2 يُظهر نشاطًا ضد تحويرات FGFR2 والطفرات المقاومة

درس Subbiah وآخرون (Mon,) هذا السؤال.

www.synapsesocial.com/papers/68e586b5b6db643587522ecb — DOI: https://doi.org/10.1158/2159-8290.27025769

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S2 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
2. Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
3. Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
4. Data from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
5. Supplementary References from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024